AVIR Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.30% compare to its pairs and should correct upwards.

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections...

Stats
Šios dienos apimtis	309 170
Vidutinė apimtis	285 631
Rinkos kapitalizacija	297.31M
EPS	$-0.750 ( Q1 \| 2024-05-14 )
Kita pelno data	( $-0.770 ) 2024-08-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.810 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00500 (0.14%)

AADI 0.00%

ABCL 1.47%

ABCM 0.04%

ABEO -0.44%

ABIO 2.17%

ABOS -0.40%

ABSI 0.29%

ABUS 0.33%

ABVX -0.22%

ACAD 0.54%

ACER -17.95%

ACET 0.00%

ACGN 1.29%

ACHL -2.44%

ACHV 1.63%

ACIU 0.00%

ACLX 0.28%

ACRV 0.73%

ACST 0.62%

ACXP 1.68%

ADAG -5.64%

ADAP 0.33%

ADGI 0.87%

ADIL 1.57%

ADMA 0.29%

ADPT -0.96%

ADTX -1.27%

ADVM -0.55%

ADXN -6.11%

AEON 11.51%

AEZS -5.44%

AFMD -0.59%

AGEN -2.52%

AGIO 0.56%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -0.95%

AKRO 0.26%

AKTX -2.70%

AKUS 0.00%

ALBO 0.00%

ALDX 0.96%

ALEC 0.44%

ALGS -0.25%

ALKS 0.60%

ALLK 0.00%

ALLO 0.00%

ALLR -0.77%

ALNA 3.16%

ALNY 0.00%

ALPN 0.00%

ALPX 0.00%

ALRN -0.31%

ALT -0.51%

ALVR 0.60%

ALXN 0.00%

ALXO -1.49%

ALZN 0.00%

AMRN -2.37%

AMTI -3.13%

ANAB -0.94%

ANEB -5.58%

ANGN 0.00%

ANIX -1.14%

ANL 0.61%

ANNX -0.56%

ANPC -3.15%

APGE 0.36%

APGN 8.48%

APGNW 30.65%

APLM 10.18%

APLS 0.92%

APLT 0.21%

APM 1.33%

APOP 0.38%

APRE 2.44%

APTO 0.68%

APTX 3.17%

APVO -0.02%

ARAV -13.39%

ARCT -0.43%

ARDS 20.48%

ARDX 0.48%

ARGX -2.25%

ARNA 0.00%

ARPO -0.90%

ARQT -0.75%

ARTL -4.55%

ARTLW 9.80%

ARVN -0.60%

ARWR 0.00%

ASLN 2.75%

ASMB -0.86%

ASND 0.41%

ATAI -0.75%

ATHA -0.38%

ATHE -1.61%

ATHX -33.50%

ATNF -4.37%

ATOS 2.17%

ATRA -2.75%

ATXI -1.66%

ATXS 0.23%

AUPH -0.90%

AURA 0.68%

AUTL -0.23%

AVBP -0.27%

AVEO 0.00%

AVIR -0.28%

AVRO -2.05%

AVTE -4.82%

AVTX 4.15%

AVXL -0.27%

AXLA 0.00%

AXSM -0.66%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.11%

BCAB 1.30%

BCDA -0.30%

BCDAW -33.33%

BCEL -1.32%

BCLI -0.05%

BCRX -0.32%

BCTX -0.68%

BCTXW 0.00%

BCYC 0.00%

BDRX 1.05%

BDTX -0.55%

BEAM -0.12%

BFRA -2.91%

BGNE -0.62%

BIOR 0.03%

BIVI 1.73%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX 2.36%

BLTE -0.72%

BLU 0.03%

BLUE -1.38%

BMEA -0.39%

BMRN 0.07%

BNOX 10.76%

BNTC 2.46%

BNTX 0.00%

BOLD 0.49%

BOLT -0.50%

BPMC -0.02%

BPTH 1.26%

BPTS -13.47%

BRNS 2.96%

BRTX -9.91%

BTAI 0.75%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -0.36%

CABA 0.00%

CADL -0.83%

CALA 60.00%

CALC -1.62%

CALT -0.64%

CAPR -0.60%

CARA 2.12%

CARM 0.97%

CASI -2.41%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 1.17%

CCCC -0.97%

CCXI 0.00%

CDAK 0.00%

CDIO -3.01%

CDIOW 0.00%

CDMO -0.40%

CDMOP 0.04%

CDT -6.11%

CDTTW 294.32%

CDTX -0.08%

CDXC -1.01%

CDXS -0.34%

CELC 1.03%

CELU 7.05%

CELUW -9.52%

CERC -1.68%

CERE 0.41%

CERO -3.40%

CEROW -44.78%

CFRX -27.95%

CGEM -1.58%

CGEN -1.02%

CGON 0.00%

CGTX 1.39%

CHMA -6.00%

CHRS -0.61%

CINC 0.00%

CING 4.48%

CINGW -48.24%

CKPT -0.49%

CLBS -16.75%

CLDX 2.89%

CLGN 0.30%

CLLS -6.07%

CLNN 9.74%

CLNNW -41.25%

CLRB 0.00%

CLSD -0.85%

CLSN -0.68%

CLVS 0.00%

CMMB 10.18%

CMND 1.82%

CMPI 0.00%

CMPX 0.00%

CMRA 0.40%

CMRAW 33.33%

CMRX 1.11%

CNCE 0.00%

CNSP -8.62%

CNST 0.00%

CNTA 0.31%

CNTB 3.13%

CNTX -1.03%

COCP 0.42%

COEPW -0.66%

COGT -0.11%

CORT 0.10%

COYA 2.22%

CPRX 0.00%

CRBP -2.67%

CRBU 1.14%

CRDF -0.75%

CRGX 0.00%

CRIS 0.73%

CRNX -0.16%

CRSP 0.40%

CRTX 2.63%

CRVO -1.89%

CRVS 0.00%

CSBR 1.19%

CTCX -8.04%

CTIC 0.06%

CTMX 3.65%

CTNM -2.94%

CTXR -1.01%

CUE -0.75%

CVAC -0.86%

CVKD 1.37%

CWBR -2.55%

CYAD -12.96%

CYCC -2.45%

CYCCP -1.79%

CYCN 6.00%

CYT -2.27%

CYTK -0.13%

CYTO -3.23%

DARE 1.19%

DAWN 0.42%

DBTX -0.81%

DBVT 1.01%

DFFN 10.28%

DICE 0.06%

DMAC -0.42%

DNLI 1.12%

DNTH 0.04%

DOMH 1.99%

DRMA 0.00%

DRMAW 0.00%

DRNA 0.00%

DRTS -1.32%

DRTSW 1.01%

DRUG 0.00%

DSGN 0.00%

DTIL -1.19%

DYAI -5.29%

EARS -1.77%

EDIT 4.34%

EDSA 1.04%

EFTR -3.13%

EFTRW -0.26%

EIGR 0.00%

ELAB -2.87%

ELDN 0.71%

ELEV -0.84%

ELOX -12.50%

ELTX -2.33%

ELVN -0.65%

ELYM -1.57%

ENGN -3.89%

ENGNW -7.06%

ENLV 1.44%

ENOB 1.79%

ENSC 0.88%

ENTA -0.75%

ENTO 0.48%

ENTX 1.45%

ENVB 0.94%

EPIX 0.00%

EPRX -0.19%

EPZM 0.00%

EQ 1.40%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.50%

ERNA 4.79%

ERYP 1.30%

ESLA 1.14%

ESLAW -9.25%

ETNB -0.23%

ETON 1.19%

ETTX 0.00%

EVAX 4.45%

EVGN -2.55%

EVLO 50.00%

EWTX -0.58%

EXAI -0.20%

EXEL -1.06%

EYEG -0.43%

EYEN -0.33%

EYPT -0.11%

FATE -0.28%

FBIO 0.00%

FBIOP 1.09%

FBLG -5.34%

FBRX -7.46%

FDMT -0.67%

FENC 0.74%

FGEN 0.00%

FHTX 9.52%

FIXX 0.77%

FMTX 0.00%

FNCH -6.25%

FOLD 0.30%

FREQ 4.76%

FRLN 0.15%

FRTX -0.54%

FSTX 0.00%

FTRE 0.58%

FULC 0.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.20%

GANX -0.76%

GBIO 1.37%

GBT 0.01%

GDTC -7.21%

GERN -0.21%

GHRS 3.42%

GLMD -3.30%

GLPG 0.93%

GLSI -1.83%

GLTO 0.00%

GLUE 0.00%

GLYC 2.57%

GMAB 0.81%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.97%

GNLX 0.00%

GNPX 1.84%

GNTA 0.00%

GOSS 13.65%

GOVX 21.43%

GOVXW -24.72%

GPCR 0.56%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -1.42%

GRTX -4.26%

GTHX 0.75%

GUTS -0.74%

GXGXW 41.67%

GYRE 0.17%

HALO 0.51%

HARP 0.09%

HCWB -9.73%

HEPA -6.36%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 0.94%

HOTH -3.73%

HOWL -0.64%

HRMY 0.00%

HRTX 0.31%

HSTO 62.16%

HUMA -0.73%

HUMAW -5.97%

IBRX 0.00%

ICCC 2.84%

ICPT 0.21%

ICU -0.26%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.13%

IFRX -3.21%

IGMS 0.14%

IKNA 1.15%

IKT 8.90%

IMAB -1.10%

IMCR -1.12%

IMGN 0.02%

IMGO 0.00%

IMMP -1.47%

IMMX -0.49%

IMNM 0.00%

IMNN -0.90%

IMPL -27.27%

IMRA 15.96%

IMRN -2.78%

IMRX 0.33%

IMTX -0.85%

IMTXW -2.70%

IMUX 1.75%

IMV 0.00%

IMVT -1.14%

INAB 0.00%

INBX -0.35%

INCY -0.06%

INDP -3.03%

INFI -52.38%

INKT -0.39%

INM 1.46%

INMB -0.60%

INO 0.00%

INSM 0.15%

INTS 0.84%

INVA 1.55%

INZY -0.22%

IOBT -6.11%

IONS 0.25%

IOVA -0.82%

IPA 0.00%

IPHA -10.64%

IPSC 0.95%

IRON -0.07%

ISEE 0.38%

ITOS -1.31%

ITRM -2.61%

IVA 2.64%

IVVD 0.00%

JAGX -0.26%

JANX 0.17%

JAZZ 0.06%

JNCE 0.00%

JSPR -0.08%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -7.96%

KALV -0.42%

KDNY 0.22%

KMPH -0.34%

KNSA -0.05%

KNTE -0.38%

KOD 0.00%

KPRX 8.51%

KPTI -0.28%

KRBP 4.17%

KRON 0.00%

KROS -2.27%

KRRO -16.54%

KRTX 0.03%

KRYS 0.24%

KTRA 10.34%

KTTA -2.85%

KTTAW 8.62%

KURA 0.19%

KYMR -0.38%

KYTX -0.38%

KZIA 8.44%

KZR -0.45%

LABP 0.57%

LBPH -0.97%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.19%

LENZ -1.30%

LEXX -0.34%

LEXXW -9.42%

LGND -0.46%

LGNDV 0.00%

LGVN -12.50%

LIAN 0.00%

LIFE 2.70%

LIPO -1.23%

LIXT 0.40%

LIXTW 27.74%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 2.99%

LPTX -1.93%

LQDA -0.23%

LRMR 1.25%

LSTA -4.97%

LTRN -2.24%

LUMO 0.00%

LVTX -1.42%

LXEO -1.05%

LXRX -0.29%

LYEL 0.00%

LYRA -1.26%

MACK 0.00%

MBIO 30.45%

MBRX -4.83%

MCRB -0.58%

MDGL 0.06%

MDNA -13.16%

MDWD 1.00%

MDXG 0.73%

MEIP 1.41%

MESO 2.12%

MGNX 0.00%

MGTA -7.74%

MGTX -1.14%

MGX 2.85%

MIRM 1.36%

MIRO 0.59%

MIST 2.96%

MITO 0.00%

MLEC -4.55%

MLECW 9.20%

MLND -5.36%

MLTX 0.09%

MLYS -0.66%

MNKD 0.42%

MNMD 0.53%

MNOV 0.00%

MNPR 3.39%

MOLN 2.88%

MOR -0.54%

MORF 1.36%

MREO 0.00%

MRKR 2.93%

MRNA -0.75%

MRNS 2.76%

MRSN 0.00%

MRTX -0.17%

MRUS -0.02%

MRVI -0.62%

MTCR -1.29%

MTEM 1.54%

MTP -18.50%

MURA -0.30%

MYMD -0.91%

NAMS -0.39%

NAMSW -7.61%

NAUT 1.17%

NBRV 0.71%

NBSE -1.56%

NBTX -5.64%

NCNA -1.64%

NERV 0.00%

NEXI -1.40%

NGM -1.28%

NGNE -3.23%

NKGN 0.78%

NKGNW 39.76%

NKTR -0.85%

NKTX -1.23%

NLSP 156.24%

NLSPW 8.38%

NMRA 0.53%

NMTR -42.97%

NOVN -24.84%

NRBO 0.45%

NRIX 6.34%

NRSN -4.95%

NRSNW 6.50%

NRXP 0.99%

NRXPW -15.65%

NRXS -6.06%

NTBL 2.92%

NTEC -12.45%

NTHI 0%

NTLA -0.16%

NTRBW -6.25%

NUVL 0.43%

NVAX -0.71%

NVCT 1.18%

NVIV -34.28%

NXTC 0.70%

NYMX -0.05%

OABI -0.47%

OABIW 13.46%

OBIO -0.87%

OBSV 0.00%

OCEA -3.21%

OCGN 2.24%

OCS -1.09%

OCUL -1.45%

OCUP 0.00%

ODT -4.27%

OKYO 0.00%

OLMA -0.76%

OMER 0.87%

OMGA 10.22%

ONCO 21.96%

ONCR -3.08%

ONCS 31.87%

ONCT -0.12%

ONCY -0.99%

ONTX -0.47%

ONVO -2.35%

OPNT 0.00%

OPT 0.80%

ORGS -1.72%

ORIC -0.13%

ORMP 0.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.26%

OVID -5.29%

OYST 0.00%

PALI 0.86%

PASG -0.99%

PBLA 9.76%

PBM -0.02%

PBYI -0.63%

PCSA 5.71%

PCVX 0.31%

PDSB 0.00%

PEPG 0.70%

PGEN -1.23%

PHAR 2.17%

PHAS 0.00%

PHAT -0.60%

PHIO 5.42%

PHIOW 36.47%

PHVS -0.53%

PHXM -5.20%

PIRS -5.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.27%

PLUR 0.00%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT 2.78%

PRAX 6.05%

PRDS 0.93%

PRLD 0.77%

PROG -3.47%

PROK 1.37%

PRQR -5.29%

PRTA 0.34%

PRTC -0.72%

PRTG 6.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 0.00%

PSTX 1.81%

PTCT 0.06%

PTE -0.82%

PTGX 0.03%

PTIXW 2.50%

PULM 3.72%

PXMD -1.92%

PYPD -0.36%

PYXS 1.09%

QLGN 17.13%

QNCX -1.41%

QNRX 3.04%

QSI 0.75%

QSIAW 0.00%

QTTB 0.00%

QURE -0.85%

RAIN -1.63%

RANI 0.00%

RAPT -0.30%

RARE -0.28%

RCKT 0.19%

REGN 0.11%

RENB 0.00%

REPL -0.13%

RETA 0.02%

REUN -0.89%

REVB 5.66%

REVBU 3.46%

REVBW 25.20%

RGLS 0.42%

RGNX 1.12%

RIGL 2.55%

RLAY 0.28%

RLMD 0.00%

RLYB 0.00%

RNA -1.52%

RNAC -1.07%

RNAZ 0.00%

RNXT 0.75%

ROIV 0.28%

ROIVW 4.56%

RPHM -0.60%

RPRX 0.04%

RPTX 1.58%

RUBY 2.70%

RVLP -32.05%

RVMD -0.16%

RVMDW -23.93%

RVNC -0.71%

RVPH 0.00%

RVPHW 11.54%

RXDX 0.09%

RXRX -0.66%

RYTM 0.46%

RYZB 0.02%

RZLT 0.00%

SABS -2.75%

SABSW -32.14%

SAGE 0.71%

SANA -0.17%

SAVA -0.80%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -8.63%

SCPH 0.00%

SCPS 0.00%

SEEL -1.16%

SEER -0.58%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 1.55%

SGMT -0.47%

SGTX -2.56%

SIOX 22.63%

SLDB -0.40%

SLGL -2.22%

SLN -1.55%

SLNO 0.38%

SLRX 2.89%

SLS -3.20%

SMMT 0.76%

SNDX 0.25%

SNGX 0.79%

SNPX -3.97%

SONN -4.75%

SPPI -0.49%

SPRB 0.49%

SPRC -2.02%

SPRO 3.13%

SRNE 20.00%

SRPT 0.18%

SRRA 0.00%

SRRK -0.34%

SRZN -1.70%

STAB 0.00%

STOK -0.26%

STRO 0.63%

STSA 0.00%

STTK 0.40%

SURF -0.93%

SVRA -0.52%

SWTX -1.40%

SYBX -0.63%

SYRS -1.75%

TALS -0.73%

TARA -0.78%

TARS 0.00%

TBPH -0.12%

TCBP 1.78%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -3.13%

TCRX -1.21%

TECH 0.07%

TENX -3.43%

TERN 0.00%

TFFP -2.05%

TGTX 0.84%

THRX 0.12%

TIL -2.06%

TLC 0.00%

TLSA 0.66%

TNGX 0.59%

TNXP 0.89%

TNYA 0.00%

TPST 0.34%

TRDA -3.61%

TRVI -0.18%

TRVN -1.88%

TSHA -8.44%

TSVT -0.49%

TTNP 1.45%

TVTX -0.27%

TYRA -0.39%

UBX 0.72%

UNCY -0.11%

URGN -7.55%

UTHR 0.08%

VACC 11.36%

VALN -2.51%

VAXX -0.11%

VBIV 1.15%

VBLT -8.77%

VCEL 0.50%

VCNX -1.54%

VCYT -0.09%

VERA -0.62%

VERU 0.50%

VERV -1.14%

VIGL -2.75%

VINC 1.05%

VIR -0.87%

VIRI -1.96%

VIRX -6.84%

VKTX -0.25%

VLON -13.04%

VNDA 0.63%

VOR 0.85%

VRCA 0.00%

VRDN -0.74%

VRNA 0.50%

VRPX -11.90%

VRTX -0.06%

VSTM 0.29%

VTGN 1.46%

VTVT -0.10%

VTYX -0.36%

VXRT 5.20%

VYGR 0.85%

VYNE 2.16%

VYNT 7.78%

WINT 5.59%

WVE -0.67%

XBIO 6.75%

XBIT -0.66%

XCUR -0.65%

XENE 0.30%

XERS 0.00%

XFOR -0.54%

XLO 0.00%

XLRN 0.00%

XNCR -0.41%

XOMA 0.00%

XOMAO -0.56%

XOMAP -0.14%

XRTX 2.97%

YMAB 0.26%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.26%

ZNTL -24.91%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-05	Sommadossi Jean-pierre	Sell	1 006	Common Stock
2024-01-31	Corcoran Andrea	Buy	44 367	Common Stock
2024-02-01	Corcoran Andrea	Sell	15 843	Common Stock
2024-01-31	Corcoran Andrea	Buy	200 000	Stock Option (Right to Buy)
2024-01-31	Corcoran Andrea	Sell	44 367	Restricted Stock Units

INSIDER POWER
71.51
Last 99 transactions
Buy: 22 764 762 \| Sell: 13 013 168

Koreliacija (AI algo v.1.1b): Undervalued: 0.30% $3.54 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.25 (neutral)

Trumpas: -0.97 (very strong negative)

Signal:(32.618) Neutral

Atea Pharmaceuticals, Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
OZEM	1
CCSB	0.906
NEWZ	0.901
GECCI	0.89
BWAQR	0.861
OPTZ	0.859
BOTT	0.855
NNAVW	0.847
EVERX	0.847
IDYA	0.843

10 Labiausiai neigiamai susiję koreliacijos
AMDL	-0.901
HPCO	-0.882
GDC	-0.874
OCEA	-0.868
PMNT	-0.864
BFRGW	-0.864
LBTYB	-0.864
ABLV	-0.861
LDTC	-0.858
ATPC	-0.856

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Atea Pharmaceuticals, Koreliacija - Valiuta/Žaliavos

-0.48
( neutral )

-0.05
( neutral )

0.00
( neutral )

-0.37
( neutral )

0.00
( neutral )

0.46
( neutral )

Atea Pharmaceuticals, Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-416 000 (0.00 %)
EPS:	$-1.630

FY	2023
Pajamos:	$0
Bruto pelnas:	$-416 000 (0.00 %)
EPS:	$-1.630

FY	2022
Pajamos:	$0
Bruto pelnas:	$-260 000 (0.00 %)
EPS:	$-1.390

FY	2021
Pajamos:	$351.37M
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$5.61

Financial Reports:

No articles found.

Atea Pharmaceuticals, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Atea Pharmaceuticals,

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.